This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 2784

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Increase, Endothelial Dysfunction leads to Occurrence, Vascular Remodeling

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Deposition of energy leads to vascular remodeling adjacent Moderate Low Cataia Ives (send email) Open for citation & comment

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
human Homo sapiens Moderate NCBI
mouse Mus musculus Moderate NCBI
rat Rattus norvegicus High NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help
Sex Evidence
Male High
Female Moderate

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help
Term Evidence
Adult Moderate
Juvenile Low
Not Otherwise Specified Moderate

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

Proper endothelial activation is a key step in the growth of new vessels through the process of angiogenesis, a process also affected by a dysfunctional endothelium (Rajashekhar et al., 2006). Regional responses to stressors are also possible, with mechanical stressors differentially affecting pressure in vessels above (superior to) and below (inferior to) the heart (Hargens & Watenpaugh, 1996; Zhang, 2001). The endothelial layer is responsive to these variations in mechanical stresses and can adapt through altering the balance between hypertrophic and hypotrophic remodeling in smooth vessel cells lining vasculature (Baeyens et al., 2016) in part through altering the progression of the acid sphingomyelinase (ASM)/ceramide (Cer) pathway (Cheng et al., 2017).

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

The strategy for collating the evidence on radiation stressors to support the relationship is described in Kozbenko et al 2022. Briefly, a scoping review methodology was used to prioritize studies based on a population, exposure, outcome, endpoint statement.

Evidence Map 2.0

ID Experimental Design Species Upstream Observation Downstream Observation Citation (first author, year) Notes

Evidence Map

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Title First Author
Biological Plausibility
Dose Concordance
Temporal Concordance
Incidence Concordance
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help
  • Lower doses (0.5 Gy and 1.6 Gy) did not show changes in vasomotion compared to control, but vascular stiffness increased at these doses (Soucy et al., 2007).  

  • Tarasova et al. (2020) showed differences in the vascular remodeling and vasoconstriction responses between skeletal and cutaneous arteries. While the two groups demonstrated differences, all vessels followed different trends showing no clear relationship between KEs.  

  • Studies exploring vasoreactivity, vascular structure and vessel stiffness endpoints in humans (Lee et al., 2020) and mice (Sofronova et al., 2015) flown in space, found changes in these endpoints to be inconsistent and/or changes were not statistically significant.  

  • C6-Cer incubation in cerebral arteries showed increased apoptosis with HU in the study by Cheng et al. (2017); however, in Su et al. (2020), there was a slight decrease in apoptosis, measured by TUNEL.  

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help

Modulating factor  

Details  

Effects on the KER  

References  

Drug 

Oxp (xanthine oxidase inhibitor) 

Treatment with Oxp after irradiation led to increased vasodilation and decreased PWV 

Soucy et al., 2007; Soucy et al., 2010; Soucy et al., 2011 

Drug 

hBMSCs (protect against vascular damage) 

Treatment with hBMSCs after irradiation led to decreased apoptosis and aortic thickness 

Shen et al., 2018 

Drug 

C6-Cer (activates the ASM/Cer pathway) 

Treatment with C6-Cer after microgravity caused increased apoptosis along with a return of proliferation to control levels 

Cheng et al., 2017; Su et al., 2020 

Drug 

dpm (ASM inhibitor) 

dpm treatment showed apoptosis and proliferation levels returned to control after microgravity 

Su et al., 2020 

Drug 

DOX (ASM inhibitor) 

Treatment with DOX after microgravity showed decreased apoptosis and increased IMT in rat carotid arteries 

Su et al., 2020 

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

There is a substantial amount of evidence for this KER from in vivo rodent models and from human studies. The sex applicability is high for males and moderate for females as many studies were done only using male animals. Most studies indicated that the animals used were adult.